Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2017.Aug.11

Announcement on Change of the Acting Spokesperson

2017.Aug.11

Announcement on Change of the Head of Finance and Accounting

2017.Jul.21

OBI Received a Civil Complaint from Taiwan Shilin District Court

2017.Jul.12

Clarification on the news article by China Times

2017.Jun.29

Clarification on the news article by Commercial Times

2017.Jun.28

Important Resolutions of AGM 2017

2017.Jun.11

Supplemental information on the approved application of Phase III clinical trial of OBI-822, the novel breast cancer drug, in China, US, and the EU

2017.Jun.01

OBI Pharma Announces Acquisition of the Novel First-in-class Anti-Cancer Drug OBI-3424 from Threshold Pharmaceuticals to be Developed as Potential Anti-Cancer Therapy for Cancers with High AKR1C3

2017.Apr.26

Announcement of explanation on the first instance judgment of the civil action between the Company against "Next Magazine"

2017.Apr.17

Announcement of explanation on the Company's criminal lawsuit against Next Magazine

News

Latest News

Events

Latest events